What Is My Care Home Actually Worth? A Realistic Guide to Valuation

What Is My Care Home Actually Worth? A Realistic Guide to Valuation

James Dixey — Founder and Managing Director    ·    8 min read    ·    James Dixey Limited

Online calculators will give you a number. Whether the number is right depends on three things they don't ask about: your CQC rating, your normalised EBITDA, and the segment of the buyer pool your business actually sits in.

EXECUTIVE SUMMARY

•  Single-home valuations in the 20–39 bed range typically trade in the £80,000–£140,000 per bed range for well-rated freehold properties, with a wide spread depending on CQC rating, occupancy, fee mix and condition. EBITDA multiples in the same band typically run 6–9x.

•  Multi-home groups attract a different buyer pool and trade at a different multiple — typically 8–10x EBITDA for well-structured 3–19 home portfolios, and 10–12x for premium groups with strong commissioner books, current Good or Outstanding ratings, and management depth.

•  The normalised EBITDA bridge is where most owner-led valuations go wrong. Reported profit understates true earning power by 20–40% in a typical owner-managed home — but only with proper documentation of personal expenses, owner remuneration normalisation and one-off costs.

•  CQC rating moves the price by more than any other single variable. An Outstanding home with strong commissioner relationships will routinely transact at the top of the range; a Requires Improvement home at the bottom or with a deal structure that reflects the regulatory risk.

Want a confidential valuation of your care business?

Our valuation calculator gives you an indicative starting point. For a properly worked-through valuation incorporating CQC, fee mix, property and management succession, the right next step is a confidential conversation.

Get a valuation  →

Why valuation is harder than it looks

Most owner-managers have a number in their head for what their care home is worth. The number usually comes from one of three places: a multiple a friend got, a price per bed someone in the local sector mentioned, or an asset valuation done by a surveyor. None of these give you the same answer, and only one of them (the multiple, properly applied) corresponds to what a serious buyer will actually pay.

A care home valuation is a function of normalised EBITDA, the multiple that applies to your specific business profile, and any property element that needs to be valued separately. Each of those three components is harder than it looks for a first-time seller. This piece walks through what each one is, where the common mistakes are, and what realistic ranges look like for a typical James Dixey Limited mandate.

Normalised EBITDA — where most valuations get the math wrong

Reported EBITDA — the figure on the bottom of your profit and loss account — is rarely the figure a buyer will pay a multiple on. In a typical owner-managed home, reported EBITDA understates the underlying earning power of the business by 20–40%, because reported profit includes adjustments a future buyer wouldn't carry: above-market owner remuneration, personal vehicle and travel expenses, family member roles paid above market rate, a one-off CQC remediation cost from two years ago, the Christmas party, the audit fee for the year you transferred to a different accountant.

Normalising EBITDA is the process of identifying and evidencing every one of these items so the buyer can see the underlying profitability of the business as it would run under their ownership. Done well, with proper documentation, the normalising bridge is the difference between selling at 6x and selling at 9x — which on a £400k EBITDA business is over £1.2m of price. Done badly, with a single "adjusted profit" number and no working underneath, every adjustment will be challenged and the buyer will discount accordingly.

The work matters. A care home with reported EBITDA of £280k and a properly documented £140k of normalising adjustments is, for valuation purposes, a £420k EBITDA business — and trades at a materially higher price.

What multiple applies

The right multiple for a care home depends on segment, structure, and quality. The ranges below are based on transactions completed in 2024–2026 across our pipeline and published transaction data from Christie & Co and others.

Single home, 20–39 beds

The most common mandate in our pipeline. Well-rated freehold homes in this range typically trade at 6–8x normalised EBITDA, with an upper end of 9x for homes with Outstanding CQC ratings, strong private-pay mix, and properties in good condition. Lower end of the range for homes with Requires Improvement ratings, high LA-funded concentration, or capex-deferred properties. Per-bed equivalents in this range typically sit at £80,000–£140,000 for the strong end, £50,000–£80,000 for the weaker end.

Small group, 3–19 homes

Groups of three to nineteen homes attract a different buyer pool — operator consolidators rather than single-home acquirers — and the multiple lifts to reflect both the scale and the buyer set. Typical range 7–10x normalised group-level EBITDA, with the upper end for groups with diversified commissioner books, current Good or Outstanding ratings across the portfolio, and a management team that runs the business without the owner in the room.

Premium group, 20+ homes

Larger groups attract institutional capital — PE platforms, US REITs, larger trade consolidators — and routinely transact at 10–12x EBITDA for well-structured platforms. The Welltower acquisitions of Barchester and HC-One in October 2025 (£5.2bn and £1.2bn respectively) represent the upper end of the institutional market; mid-cap PE-backed care platforms typically transact at 10–11x with appropriate management equity and earn-out structures.

Specialist care — SEN, complex needs, learning disability

Specialist care commands a premium over mainstream residential. Typical range 8–12x EBITDA for SEN and complex-needs providers with dual Ofsted/CQC registration, strong LA commissioner relationships, and credible management succession. The economics are different because the unit revenue is materially higher and the regulatory moat genuinely deeper.

How CQC rating affects the price

Of all the variables that affect a care home valuation, CQC rating is the single biggest. An Outstanding home routinely trades at the top of its range. A Good home with an upward trajectory (improving from a previous Requires Improvement) trades at the middle. A Requires Improvement home, particularly one with multiple breaches or open enforcement actions, trades at the bottom of the range or with a deal structure that reflects the regulatory risk — usually a discount, an earn-out tied to the next inspection, or both.

What buyers actually care about, more than the snapshot rating, is the trajectory. A home that has held a Good rating for four consecutive inspections is genuinely more valuable than a home with a single-inspection Good preceded by Requires Improvement. The compounding effect of regulatory stability is real and buyers pay for it. Conversely, even an Outstanding home with one inspection in the rating cycle that dropped to Good will be priced carefully — the question buyers ask is whether the drop was one-off or trend.

Property: the second variable

Most care home valuations are presented as a single number, but operationally there are usually two assets being valued: the operating business and the property. For freehold operators, the property element is often a substantial portion of the total deal value — and in some structures (sale-and-leaseback, OpCo/PropCo split, REIT acquisition) it is valued and transacted entirely separately from the trading business.

For a typical 30-bed freehold home in a good catchment, the property element might represent 60–70% of total enterprise value, with the operating business representing the remaining 30–40%. Owners with strong freehold assets in good catchments often discover that the property is worth more to a different buyer than the operating business is to a trade consolidator — which is the underlying logic of an OpCo/PropCo split. Done well, the parallel-process structure can add meaningfully to total proceeds.

Why online calculators get it wrong

A typical online valuation tool asks for revenue, EBITDA, beds and rating, and produces a number. The number is usually within range, but the range is wide. What the calculator cannot do is normalise your EBITDA properly, assess your CQC trajectory rather than the snapshot, identify whether your buyer pool is single-home operators or institutional capital, or surface the property structure that might add 20% to the total proceeds.

Use the calculator as a starting point. Treat its number as the middle of a range that could be 25% higher or 25% lower depending on the factors above. For a properly worked-through valuation, the right next step is a 30-minute confidential conversation.

What "realistic" actually looks like

For a typical James Dixey Limited mandate — a single-home or small-group care business with normalised EBITDA between £200k and £1.5m — the realistic price range, before going to market, is often 30–40% wide. The work of preparation, marketing and competitive process is what narrows that range and lifts the achievable outcome from the middle to the top. For an owner twelve to eighteen months from sale, the work that compresses the range starts with the normalised EBITDA bridge and a clear-eyed view of the CQC trajectory. Everything else follows.

Related: Who actually buys care homes in 2026? A tour of the buyer universe.  (/insights/who-actually-buys-care-homes-2026)

Selling a care home or care group?

The first conversation is always confidential and never costs anything. We can usually give you a defensible indicative range within a few days of seeing your management accounts and CQC history.

Get a valuation  →

SOURCES

[1] Christie & Co Care Market Review 2025: H1 2025 transaction data, buyer-mix segmentation, average price per bed by region and rating.

[2] Welltower Inc. SEC filings October 2025 (Barchester £5.2bn, HC-One £1.2bn). CareTrust REIT / Care REIT plc transaction (May 2025, $840m, 132 UK care homes).

James Dixey Limited — Specialist M&A for regulated, owner-managed businesses in Care, Education, Fire & Security and Other Regulated Services.